$IDRA IDERA PHARMACEUTICALS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDERA PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in IDERA PHARMACEUTICALS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
IDERA PHARMACEUTICALS, INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| 14159 capital (GP), LLC | 10% Owner | 12,867 | 20,073 | Jul 30 2008 | |||
| AGRAWAL SUDHIR | President of Research | 152,160 | 237,370 | Jan 06 2017 | |||
| AGRAWAL SUDHIR | CEO & CSO | 26,178 | 40,838 | May 17 2007 | |||
| AGRAWAL SUDHIR | President of Research | 126,277 | 196,992 | Dec 12 2014 | |||
| Alison Taunton-Rigby | Director | 0 | 0 | Jun 16 2009 | |||
| ANDERSEN ROBERT G | CFO & VP Oper. and Planning | 96,577 | 150,660 | Dec 01 2005 | |||
| ANDERSEN ROBERT G | CFO & VP Oper. and Planning | 15,744 | 24,561 | May 17 2007 | |||
| Arbeit Robert D. | VP Clinical Development | 0 | 0 | Dec 12 2013 | |||
| Arbeit Robert D. | VP Clinical Development | 0 | 0 | Nov 15 2012 | |||
| Arcudi III Louis J | Chief Financial Officer | 0 | 0 | Dec 12 2014 | |||
| Arcudi Louis J. | Chief Financial Officer | 0 | 0 | Aug 15 2018 | |||
| Baker Biotech Capital (GP), LLC | 10% Owner | 209,110 | 326,212 | Jul 30 2008 | |||
| BAKER BROS ADVISORS LLC | 10% Owner | 350,721 | 547,125 | Jul 03 2019 | |||
| Baker Bros. Capital (GP), LLC | 10% Owner | 40,077 | 62,520 | Jul 30 2008 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 11,175,900 | 17,434,404 | Aug 17 2006 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 418,030 | 652,127 | Jul 30 2008 | |||
| BAKER JULIAN | Director | 1,017,950 | 1,588,002 | Jan 05 2017 | |||
| BAKER JULIAN | Director | 6,323,855 | 9,865,214 | Feb 17 2015 | |||
| Bexon Alice | V.P. Clinical Development | 0 | 0 | Dec 24 2009 | |||
| BRENNER LOUIS MD | Chief Medical Officer | 0 | 0 | Dec 12 2014 | |||
| Casey Mark J | Senior VP & General Counsel | 34,450 | 53,742 | Jan 05 2018 | |||
| Csimma Cristina | Director | 0 | 0 | May 19 2020 | |||
| DOUGHERTY MICHAEL R | Director | 37,645 | 58,726 | Jan 06 2021 | |||
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | 36,485 | 56,917 | Jul 23 2020 | |||
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | 0 | 0 | Jan 28 2015 | |||
| GERAGHTY JAMES A | Director | 104,770 | 163,441 | Jan 06 2021 | |||
| GERAGHTY JAMES A | Director | 412,649 | 643,732 | Jun 11 2014 | |||
| Goldberg Mark Alan | Director | 38,099 | 59,434 | Jan 06 2021 | |||
| Goldberg Mark Alan | Director | 0 | 0 | Jun 11 2014 | |||
| GOWEN MAXINE | Director | 17,543 | 27,367 | Jun 10 2021 | |||
| HARTLEY C KEITH | Director | 92,434 | 144,197 | Aug 16 2013 | |||
| Horobin Joanna | Chief Medical Officer | 20,144 | 31,425 | Jul 11 2019 | |||
| Karr Robert W | Director | 4,390 | 6,848 | Jan 04 2008 | |||
| Karr Robert W | Director | 6,299 | 9,826 | Jun 11 2014 | |||
| Kirby John J. | CHIEF FINANCIAL OFFICER | 27,632 | 43,106 | Mar 29 2021 | |||
| Lim Bryant David | SVP AND GENERAL COUNSEL | 30,434 | 47,477 | Mar 29 2021 | |||
| MacCoss Malcolm | Director | 3,753 | 5,855 | Jul 03 2014 | |||
| MARTIN RUSSELL | Senior VP of Drug Development | 98,750 | 154,050 | Apr 02 2004 | |||
| MILANO VINCENT | President & CEO | 208,611 | 325,433 | Jan 12 2021 | |||
| MILANO VINCENT | President and CEO | 200,000 | 312,000 | Dec 15 2014 | |||
| MUELLER HANS | Director | 10,000 | 15,600 | Jun 14 2011 | |||
| PIEN HOWARD H | Director | 45,457 | 70,913 | Oct 05 2020 | |||
| Pillar Invest Corp | 10% Owner | 1,931,893 | 3,013,753 | Mar 31 2021 | |||
| Pillar Invest Corp | Director | 0 | 0 | Dec 16 2014 | |||
| Pillar Pharmaceuticals I LP | Director | 6,266,175 | 9,775,233 | Feb 11 2014 | |||
| REARDON WILLIAM S | Director | 32,973 | 51,438 | Jun 22 2018 | |||
| RIGBY ALISON TAUNTON | Director | 0 | 0 | Jan 08 2008 | |||
| SCHAFER CAROL | Director | 48,488 | 75,641 | Jan 06 2021 | |||
| Senator Investment Group LP | 10% Owner | 2,724,700 | 4,250,532 | Apr 25 2012 | |||
| Slater Eve Elizabeth | Director | 0 | 0 | Jun 11 2015 | |||
| Slater Eve Elizabeth | Director | 0 | 0 | Jun 11 2014 | |||
| SOLAND DANIEL B | CHIEF OPERATING OFFICER | 28,843 | 44,995 | Mar 05 2021 | |||
| Sullivan Timothy M | VP Development Programs | 0 | 0 | Dec 18 2006 | |||
| Sullivan Timothy M | VP Development Programs | 24,914 | 38,866 | May 29 2014 | |||
| Tarka Elizabeth Ann | CHIEF MEDICAL OFFICER | 13,237 | 20,650 | Mar 29 2021 | |||
| Wolf John Peter III | General Counsel | 0 | 0 | Dec 12 2014 | |||
| WYNGAARDEN JAMES B | Director | 37,969 | 59,232 | Jun 14 2011 | |||
| WYNGAARDEN JAMES B | Director | 221,318 | 345,256 | Jan 06 2005 | |||
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | 36,358 | 56,718 | Jan 14 2020 | |||
| ZAMECNIK PAUL C | Director | 104,622 | 163,210 | Jan 08 2008 | |||
| ZEIN YOUSSEF EL | Director | 534,980 | 834,569 | Oct 04 2017 | |||
| ZEIN YOUSSEF EL | Director | 228,853 | 357,011 | May 09 2007 | |||
| ZEIN YOUSSEF EL | Director | 486,101 | 758,318 | Dec 16 2014 |